Universität zu Köln

Wolf, J., Schneider, C-P, Potzner, M., Arratia, Cazorla P., Shen, J., Branle, F. and von Pawel, J. (2015). The phase II ASCEND-7 (CLDK378A2205) trial: Ceritinib in patients (pts) with ALK-rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) metastatic to the brain and/or leptomeninges. Oncol. Res. Treat., 38. S. 138 - 139. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Wolf, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Schneider, C-P UNSPECIFIED UNSPECIFIED UNSPECIFIED Potzner, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Arratia, Cazorla P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Shen, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Branle, F. UNSPECIFIED UNSPECIFIED UNSPECIFIED von Pawel, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-390656
Journal or Publication Title:	Oncol. Res. Treat.
Volume:	38
Page Range:	S. 138 - 139
Date:	2015
Publisher:	KARGER
Place of Publication:	BASEL
ISSN:	2296-5262
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/39065